FUJIFILM América Latina
  • Inicio
  • Tecnologías
  • Medwork
  • Productos
    • Sistemas de Endoscopia
    • Fujifilm Accesorios
  • Distribuidores
  • Noticias y Eventos
  • Sobre Fujifilm
  • Soporte y Contacto
Select Page

FUJIFILM ANNOUNCES LAUNCH OF FUJIFILM TOYAMA CHEMICAL

A company for research, development, manufacture and sale of diagnostic and therapeutic drugs

FUJIFILM Corporation (President: Kenji Sukeno) announces the launch of FUJIFILM Toyama Chemical Co., Ltd (President: Junji Okada) on October 1, 2018. The company will engage in the research, development, manufacture and sale of diagnostic and therapeutic drugs.

FUJIFILM Toyama Chemical was formed through the merger of TOYAMA CHEMICAL CO., LTD. (Toyama Chemical), a company engaged in the research, development, manufacture and sale of small molecule pharmaceuticals and FUJIFILM RI Pharma Co., Ltd., a company engaged in the research, development, manufacture and sale of radiopharmaceuticals in order to accelerate the development of diagnostic and therapeutic drugs.

Together with FUJIFILM Corporation, engaging in activities including new drug research, FUJIFILM Toyama Chemical will seek to develop new diagnostic and therapeutic radiopharmaceuticals and other new pharmaceuticals with unique mechanisms of action to address areas of significant unmet medical needs in the fields of oncology, central nervous system disorders and infectious diseases. In addition, FUJIFILM Toyama Chemical will also strive to develop new drugs that harness “drug delivery systems” designed to precisely deliver the required dose of pharmaceuticals to designated areas of the body at the necessary time. The company will leverage the in vitro diagnostic devices and reagents owned by FUJIFILM Corporation in addition to diagnostics drugs in order to expand its product portfolio to provide total solutions for patients at all stages from diagnosis through to treatment.

Pharmaceuticals for which Toyama Chemical had acquired manufacturing and marketing approval and held sales rights are currently being sold by Taisho Toyama Pharmaceutical Co., Ltd., but from April 1, 2019 onwards, these products will be sold by FUJIFILM Toyama Chemical. However, the antibiotic combination product consisting of semisynthetic antibiotic and β-lactamase inhibitor Zosyn, jointly developed together with Taiho Pharmaceutical Co., Ltd., will be sold by Taiho Pharmaceutical Co., Ltd. which has the license of manufacturing and distribution from April 1 2019 onwards.

Through its engagement in the pharmaceuticals business, principally through the business activities of FUJIFILM Toyama Chemical, Fujifilm is committed to expanding its business through the creation of innovative pharmaceuticals, while also contributing to resolve various issues facing society.

Overview of FUJIFILM Toyama Chemical Co., Ltd.

Company Name FUJIFILM Toyama Chemical Co.,Ltd.
Address 14-1, Kyobashi 2-Chome, Chuo-ku, Tokyo Japan
Capital 490 million yen (100% owned by FUJIFILM Corporation)
Main Business Activities Research, development, manufacture, sale, export, and import of pharmaceuticals (diagnostic and therapeutic agents) and related devices
Directors Director and Chairperson Kenji Sukeno
Representative Director and President, Corporate Vice President   Junji Okada
Director and Senior Executive Vice President Yoshimitsu Ando
Director and Senior Executive Vice President  Shunichiro Ishikawa
Director and Executive Vice President Kozo Kobayashi
Outside Director   Takatoshi Ishikawa
Outside Director  Toshikazu Ban
Auditor Akira Fujisawa
Outside Auditor Tetsuo Imada
Corporate Vice President Hiroyuki Kasahara
Corporate Vice President Ryosuke Yamada
Corporate Vice President Takahiro Sanzen
Corporate Vice President Takao Yamamoto
Corporate Vice President Toshiya Morita

For inquiries on information in this media release, contact:

Media contact:  Corporate Communications Division TEL:+81 3-6271-2000
Other: Pharmaceutical Products Division TEL:+81 3-6271-2171

###

Política de privacidad      Condiciones de uso

© FUJIFILM Corporation
Cookies are important to the proper functioning of a site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality and deliver content tailored to your interest.
By continuing to use this site you are giving us your consent to do this. For more information you can read our Privacy Policy. Accept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT